SCHEMBL26778952

SCHEMBL26778952

c1ccc(-c2ccc(N(c3ccccc3)c3cccc4oc5cc(-c6nc(-c7ccccc7)nc(-c7ccc8c(c7)oc7ccccc78)n6)ccc5c34)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.35
MMP13 P45452 1/20 0.35
AHR P35869 2/20 0.35
MAPT P10636 4/20 0.34
KMT2A Q03164 2/20 0.34
POLB P06746 2/20 0.34
LMNA P02545 2/20 0.34
TSHR P16473 2/20 0.34
HTT P42858 1/20 0.34
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.34
MEN1 O00255 1/20 0.34
HCRTR1 O43613 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
KDM1A O60341 1/20 0.33
GAA P10253 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HTR2B P41595 1/20 0.33
PDE5A O76074 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979703 0.99 MMP12 (0.36) MMP12MMP13AHRMAPTKMT2A
SCHEMBL26778954 0.97 PLA2G2A (0.34) MMP12MMP13AHRMAPTKMT2A
SCHEMBL26779205 0.97 MMP12 (0.34) MMP12MMP13AHRMAPTKMT2A
SCHEMBL25978011 0.97 MMP12 (0.34) MMP12MMP13AHRMAPTKMT2A
SCHEMBL26778684 0.96 KMT2A (0.33) MAPTKMT2APOLBLMNATSHR
SCHEMBL25978370 0.96 KMT2A (0.33) MAPTKMT2APOLBLMNATSHR
SCHEMBL26778644 0.96 KMT2A (0.33) MAPTKMT2APOLBLMNATSHR
SCHEMBL25978390 0.96 KMT2A (0.33) MAPTKMT2APOLBLMNATSHR
SCHEMBL26778689 0.95 MAPT (0.35) MMP12MMP13AHRMAPTKMT2A
SCHEMBL26778948 0.95 KMT2A (0.33) MMP12MMP13MAPTKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MMP12 4355/4885MMP13 4837/4885AHR 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.